What is a stock summary page? Click here for an overview.
Business Description
Health Catalyst Inc
NAICS : 621610
SIC : 8099
ISIN : US42225T1079
Compare
Compare
Traded in other countries / regions
HCAT.USA2YP.Germany Index Membership
Russell 2000Russell 3000 IPO Date
2019-07-25Description
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.97 | |||||
| Equity-to-Asset | 0.43 | |||||
| Debt-to-Equity | 1.1 | |||||
| Debt-to-EBITDA | -37.76 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -1.24 | |||||
| Beneish M-Score | -2.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 57 | |||||
| 3-Year FCF Growth Rate | 67.2 | |||||
| 3-Year Book Growth Rate | -16.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 36.9 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 9.75 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.47 | |||||
| 9-Day RSI | 48.51 | |||||
| 14-Day RSI | 44.54 | |||||
| 3-1 Month Momentum % | -23.83 | |||||
| 6-1 Month Momentum % | -45.42 | |||||
| 12-1 Month Momentum % | -21.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.43 | |||||
| Quick Ratio | 1.43 | |||||
| Cash Ratio | 1.2 | |||||
| Days Sales Outstanding | 66.17 | |||||
| Days Payable | 21.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.8 | |||||
| Shareholder Yield % | -23.81 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.92 | |||||
| Operating Margin % | -22.77 | |||||
| Net Margin % | -22.67 | |||||
| FCF Margin % | -0.6 | |||||
| ROE % | -19.29 | |||||
| ROA % | -9.24 | |||||
| ROIC % | -12.94 | |||||
| 3-Year ROIIC % | 23.44 | |||||
| ROC (Joel Greenblatt) % | -134.16 | |||||
| ROCE % | -9.97 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 13.22 | |||||
| PE Ratio without NRI | 13.93 | |||||
| PEG Ratio | 0.39 | |||||
| PS Ratio | 0.76 | |||||
| PB Ratio | 0.68 | |||||
| Price-to-Tangible-Book | 13.03 | |||||
| Price-to-Operating-Cash-Flow | 15.96 | |||||
| EV-to-EBIT | -5.13 | |||||
| EV-to-EBITDA | -25.09 | |||||
| EV-to-Forward-EBITDA | -26.66 | |||||
| EV-to-Revenue | 0.87 | |||||
| EV-to-Forward-Revenue | 0.8 | |||||
| EV-to-FCF | -145.32 | |||||
| Price-to-GF-Value | 0.39 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.58 | |||||
| Price-to-Graham-Number | 2.83 | |||||
| Earnings Yield (Greenblatt) % | -19.49 | |||||
| FCF Yield % | -0.67 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HCAT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Health Catalyst Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 306.584 | ||
| EPS (TTM) ($) | -1.15 | ||
| Beta | 1.73 | ||
| 3-Year Sharpe Ratio | -0.82 | ||
| 3-Year Sortino Ratio | -1 | ||
| Volatility % | 46.28 | ||
| 14-Day RSI | 44.54 | ||
| 14-Day ATR ($) | 0.330279 | ||
| 20-Day SMA ($) | 4.0505 | ||
| 12-1 Month Momentum % | -21.25 | ||
| 52-Week Range ($) | 3.555 - 9.24 | ||
| Shares Outstanding (Mil) | 70.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Health Catalyst Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Health Catalyst Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Health Catalyst Inc Frequently Asked Questions
What is Health Catalyst Inc(HCAT)'s stock price today?
The current price of HCAT is $3.91. The 52 week high of HCAT is $9.24 and 52 week low is $3.56.
When is next earnings date of Health Catalyst Inc(HCAT)?
The next earnings date of Health Catalyst Inc(HCAT) is 2025-05-07.
Does Health Catalyst Inc(HCAT) pay dividends? If so, how much?
Health Catalyst Inc(HCAT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers